(Q53431585)
Statements
An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. II. A genotypic marker that predicts tumorigenic responsiveness. (English)
K L Thompson
B A Rosenzweig
F D Sistare
1 July 1998
26
4
548-555
1 reference
1 reference
1 reference
1 reference